tradingkey.logo
tradingkey.logo
Suchen

Mesa Laboratories Inc

MLAB
Zur Watchlist hinzufügen
105.540USD
+1.150+1.10%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
583.10MMarktkapitalisierung
160.59KGV TTM

mehr Informationen über Mesa Laboratories Inc Unternehmen

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Mesa Laboratories Inc Informationen

BörsenkürzelMLAB
Name des UnternehmensMesa Laboratories Inc
IPO-datumFeb 29, 1984
CEOOwens (Gary M)
Anzahl der mitarbeiter730
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 29
Addresse12100 W 6th Ave
StadtLAKEWOOD
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl80228
Telefon13039878000
Websitehttps://mesalabs.com
BörsenkürzelMLAB
IPO-datumFeb 29, 1984
CEOOwens (Gary M)

Führungskräfte von Mesa Laboratories Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.85%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
46.44K
+10.21%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--
Mr. Shiraz S. Ladiwala
Mr. Shiraz S. Ladiwala
Lead Independent Director
Lead Independent Director
--
--
Mr. R. Tony Tripeny
Mr. R. Tony Tripeny
Independent Director
Independent Director
--
--
Mr. Mark Christophe Capone
Mr. Mark Christophe Capone
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Gary M. Owens
Mr. Gary M. Owens
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
148.26K
+7.80%
Dr. John James Sullivan, Ph.D.
Dr. John James Sullivan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
70.06K
-2.85%
Mr. John V. Sakys
Mr. John V. Sakys
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
46.44K
+10.21%
Ms. Jennifer S. Alltoft
Ms. Jennifer S. Alltoft
Independent Director
Independent Director
--
--
Ms. Shannon M. Hall
Ms. Shannon M. Hall
Independent Director
Independent Director
--
--
Mr. Brian Archbold
Mr. Brian Archbold
Senior Vice President - Continuous Improvement
Senior Vice President - Continuous Improvement
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Mesa Laboratories Inc?

Die fünf größten Anteilseigner von Mesa Laboratories Inc sind: Mr. Gary M. Owens

Wie viele Institutionen halten Anteile an Mesa Laboratories Inc (MLAB)?

Mit Stand vom 2026Q1 halten 397 Institutionen Anteile an Mesa Laboratories Inc, mit einem Gesamtmarktwert von etwa 5.55M, was 100.49% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -254194.00 gestiegen.

Was ist die größte Einnahmequelle von Mesa Laboratories Inc?

Am 2026Q1 erzielte das Geschäft mit Discrete Revenues- Consumables für Mesa Laboratories Inc den höchsten Umsatz in Höhe von 36.73M, was 56.40% des Gesamtumsatzes entspricht.